Please use this identifier to cite or link to this item:
|Title:||Characterization of FOXO acetylation|
Eric W.F. Lam
Imperial College London
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas
|Keywords:||Biochemistry, Genetics and Molecular Biology|
|Citation:||Methods in Molecular Biology. Vol.1890, (2019), 77-90|
|Abstract:||© 2019, Springer Science+Business Media, LLC, part of Springer Nature. FOXO3 is a tumor suppressor that orchestrates the expression of genes that regulate cell cycle progression, apoptosis, metabolism, oxidative stress, and other important cellular processes. Its inactivation is closely associated with tumorigenesis and cancer progression. On the other hand, sirtuin proteins have been demonstrated to be able to deacetylate, thus causing FOXO3 inactivation at the posttranslational level. Therefore, targeting sirtuin proteins renders new avenues for breast cancer treatment. Here, we describe three procedures for studying FOXO3 posttranslational modifications controlled by sirtuin proteins in cancer cells.|
|Appears in Collections:||Scopus 2019|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.